Mn Services Vermogensbeheer B.V. Merck & Co., Inc. Transaction History

Mn Services Vermogensbeheer B.V.

$14.3 Billion
Q3 2024

A detailed history of Mn Services Vermogensbeheer B.V. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 978,599 shares of MRK stock, worth $95.4 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

978,599

Previous 1,002,899 2.42%

Holding current value

$95.4 Million

Previous $124 Million 10.49%

% of portfolio

0.78%

Previous 0.9%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$111.15 - $128.97 $2.7 Million - $3.13 Million	-24,300 Reduced 2.42%	978,599 $111 Million
Q2 2024 Jul 25, 2024	SELL	$123.8 - $132.96 $1.89 Million - $2.03 Million	-15,300 Reduced 1.5%	1,002,899 $124 Million
Q1 2024 Apr 29, 2024	SELL	$113.24 - $131.95 $21 Million - $24.5 Million	-185,400 Reduced 15.4%	1,018,199 $134 Million
Q4 2023 Jan 29, 2024	SELL	$100.18 - $109.02 $2.98 Million - $3.24 Million	-29,700 Reduced 2.41%	1,203,599 $131 Million
Q3 2023 Oct 25, 2023	BUY	$102.95 - $114.33 $2.17 Million - $2.41 Million	21,100 Added 1.74%	1,233,299 $127 Million
Q2 2023 Aug 09, 2023	SELL	$108.61 - $118.38 $4.96 Million - $5.41 Million	-45,700 Reduced 3.63%	1,212,199 $140 Million
Q1 2023 Apr 26, 2023	BUY	$102.94 - $114.86 $4.48 Million - $5 Million	43,500 Added 3.58%	1,257,899 $134 Million
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $16.6 Million - $21.3 Million	-189,700 Reduced 13.51%	1,214,399 $135 Million
Q3 2022 Nov 01, 2022	SELL	$84.53 - $94.96 $7.4 Million - $8.32 Million	-87,600 Reduced 5.87%	1,404,099 $121 Million
Q2 2022 Aug 03, 2022	SELL	$83.49 - $94.64 $26.9 Million - $30.5 Million	-322,000 Reduced 17.75%	1,491,699 $136 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $8.64 Million - $9.68 Million	-117,500 Reduced 6.08%	1,813,699 $149 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $3.06 Million - $3.84 Million	42,400 Added 2.24%	1,931,199 $148 Million
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $2.39 Million - $2.63 Million	33,300 Added 1.79%	1,888,799 $142 Million
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $26.5 Million - $29.3 Million	-376,700 Reduced 16.88%	1,855,499 $122 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $1.97 Million - $2.19 Million	27,500 Added 1.25%	2,232,199 $183 Million
Q3 2020 Nov 04, 2020	BUY	$73.18 - $82.95 $2.55 Million - $2.89 Million	34,900 Added 1.61%	2,204,699 $183 Million
Q2 2020 Jul 23, 2020	SELL	$70.42 - $80.13 $2.68 Million - $3.04 Million	-38,000 Reduced 1.72%	2,169,799 $168 Million
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $8.81 Million - $12.2 Million	-139,100 Reduced 5.93%	2,207,799 $170 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $5.83 Million - $6.57 Million	75,100 Added 3.31%	2,346,899 $213 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $72 Million - $78.5 Million	946,495 Added 71.42%	2,271,799 $191 Million
Q2 2019 Jul 25, 2019	SELL	$69.84 - $81.59 $10.6 Million - $12.4 Million	-151,400 Reduced 10.25%	1,325,304 $111 Million
Q1 2019 May 06, 2019	BUY	$69.58 - $79.36 $173,950 - $198,400	2,500 Added 0.17%	1,476,704 $123 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $68 Million - $78.9 Million	1,042,299 Added 241.33%	1,474,204 $98.5 Million
Q3 2018 Nov 02, 2018	BUY	$57.69 - $67.84 $173,070 - $203,520	3,000 Added 0.7%	431,905 $30.6 Million
Q1 2018 May 11, 2018	BUY	$50.96 - $59.23 $173,264 - $201,382	3,400 Added 0.8%	428,905 $23.4 Million
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $1.32 Million - $1.58 Million	-25,600 Reduced 5.67%	425,505 $19.9 Million
Q3 2017 Nov 01, 2017	BUY	$58.67 - $63.13 $26.5 Million - $28.5 Million	451,105	451,105 $28.9 Million

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.

Account

Mn Services Vermogensbeheer B.V. Merck & Co., Inc. Transaction History